RNA test might reveal early cancer, offer drug target

From Washington, D.C., at a meeting of the American Association for Cancer Research

By analyzing snippets of genetic material called microRNAs in the intestinal cells of people with colorectal cancer, researchers have devised a technique that might reveal which cancers are at the highest risk of recurrence. The finding could also open the way for new drugs targeting aberrant microRNAs that contribute to the malignancy.